Active Discomfort Management System

About AccendoWave

AccendoWave is a private, early-stage medical device company founded in 2019 and headquartered in San Francisco. It has developed a commercial-stage, non-invasive neuromodulation system designed as an opioid alternative for pain management, leveraging EEG-based biofeedback and software. The company appears to be in early commercial deployment, with a published case study involving Samsung and references to hospital trials, positioning it to address stringent hospital pain management requirements. Its business model likely involves the sale or lease of its hardware and software system to healthcare institutions.

Therapeutic Areas